These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9337674)

  • 1. Phase II trials in the EORTC. The Protocol Review Committee, the Data Center, the Research and Treatment Division, and the New Drug Development Office. European Organization for Research and Treatment of Cancer.
    Eur J Cancer; 1997 Aug; 33(9):1361-3. PubMed ID: 9337674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scientific review of EORTC trials: the functioning of the New Treatment Committee and Protocol Review Committee.
    Lardot C; Steward W; Van Glabbeke M; Armand JP
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S24-30. PubMed ID: 11858960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The European Organization for Research and Treatment for Cancer (EORTC) strategy for quality assurance in surgical clinical research: Assessment of the past and moving towards the future.
    Tanis E; Caballero C; Collette L; Verleye L; den Dulk M; Lacombe D; Schuhmacher C; Werutsky G
    Eur J Surg Oncol; 2016 Aug; 42(8):1115-22. PubMed ID: 27241924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life as an endpoint in EORTC clinical trials. European Organization for Research and Treatment for Cancer.
    Kiebert GM; Curran D; Aaronson NK
    Stat Med; 1998 Mar 15-Apr 15; 17(5-7):561-9. PubMed ID: 9549805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [European Organization for Research and Treatment of Cancer (EORTC): objectives, realizations and future perspectives].
    Meunier F
    Bull Mem Acad R Med Belg; 1992; 147(8-9):334-42; discussion 342-4. PubMed ID: 1286412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality assurance in surgical oncology (QASO) within the European Organization for Research and Treatment of Cancer (EORTC): current status and future prospects.
    Landheer ML; Therasse P; van de Velde CJ
    Eur J Cancer; 2001 Aug; 37(12):1450-62. PubMed ID: 11506950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in clinical cancer trials: experience and perspective of the European Organization for Research and Treatment of Cancer.
    Kiebert GM; Kaasa S
    J Natl Cancer Inst Monogr; 1996; (20):91-5. PubMed ID: 8750477
    [No Abstract]   [Full Text] [Related]  

  • 9. Feasibility of the EORTC/NCIC Trial Protocol in a Neurosurgical Outpatient Unit: The Case for Neurosurgical Neuro-Oncology.
    Rapp M; Sadat H; Slotty PJ; Steiger HJ; Budach W; Sabel M
    J Neurol Surg A Cent Eur Neurosurg; 2015 Jul; 76(4):298-302. PubMed ID: 25915500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EORTC-Breast Cancer Cooperative Group clinical research programme in early breast cancer. EORTC-BCCG.
    Piccart MJ; van de Velde CJ
    Recent Results Cancer Res; 1998; 152():447-52. PubMed ID: 9928579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of life evaluation in oncological clinical trials - the EORTC model. The EORTC Quality of Life Study Group.
    de Haes J; Curran D; Young T; Bottomley A; Flechtner H; Aaronson N; Blazeby J; Bjordal K; Brandberg Y; Greimel E; Maher J; Sprangers M; Cull A
    Eur J Cancer; 2000 May; 36(7):821-5. PubMed ID: 10785585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticancer Drug Development: The Way Forward.
    Connors T
    Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol information provides opportunity for patient safety and quality improvement.
    George TJ; Leather H
    J Clin Oncol; 2011 Jun; 29(18):e563. PubMed ID: 21576645
    [No Abstract]   [Full Text] [Related]  

  • 14. United Kingdom Cancer Research Campaign approach to quality-of-life research in cancer clinical trials.
    Hopwood P
    J Natl Cancer Inst Monogr; 1996; (20):103-5. PubMed ID: 8750479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to improve the clinical development paradigm and its division into phases I, II and III.
    Bamberger M; Moore N; Lechat P;
    Therapie; 2011; 66(4):331-4, 327-30. PubMed ID: 21851796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisions of general guidelines for the preclinical toxicology of new cytotoxic anticancer agents in Europe. The Cancer Research Campaign (CRC) Phase I/II Clinical Trials Committee and the European Organization for Research and Treatment of Cancer (EORTC) New Drug Development Office.
    Burtles SS; Newell DR; Henrar RE; Connors TA
    Eur J Cancer; 1995; 31A(3):408-10. PubMed ID: 7786609
    [No Abstract]   [Full Text] [Related]  

  • 17. Adaptive designs at European Organisation for Research and Treatment of Cancer (EORTC) with a focus on adaptive sample size re-estimation based on interim-effect size.
    Mauer M; Collette L; Bogaerts J;
    Eur J Cancer; 2012 Jun; 48(9):1386-91. PubMed ID: 22281098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From bench to clinical trials the EORTC experience in biology-based clinical cancer research.
    Tryfonidis K; Hartmann K; Morfouace M; Lacombe D
    J Egypt Natl Canc Inst; 2017 Dec; 29(4):171-176. PubMed ID: 29122511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of instruments for measuring quality of life in patients with lung cancer.
    Hollen PJ; Gralla RJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):31-40. PubMed ID: 8610235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The EORTC and drug development. European Organisation for Research and Treatment of Cancer.
    Lacombe D; Fumoleau P; Zwierzina H; Twelves C; Hakansson L; Jayson G; Lehmann F; Verweij J; ;
    Eur J Cancer; 2002 Mar; 38 Suppl 4():S19-23. PubMed ID: 11858959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.